Department of Otolaryngology - Head and Neck Surgery, CHUV, University of Lausanne, Lausanne, Switzerland.
Head and Neck Unit, The Royal Marsden Hospitals NHS Foundation Trust, London, UK.
Head Neck. 2022 Oct;44(10):2335-2341. doi: 10.1002/hed.27114. Epub 2022 Jun 2.
We report on the first clinical experience with the robotic-assisted extended "Sistrunk" approach (RESA) for access to constrained spaces of the upper aerodigestive tract. This prospective case cohort study include six patients that underwent RESA if transoral exposure could not be achieved. Three patients received previous radiation. Patients were postoperatively followed until week 16 for perioperative complications, surgical margins, and functional outcomes. In all patients RESA allowed adequate exposure and resection with negative margins. Three patients who underwent salvage surgery experienced a minor or intermediate grade postoperative bleeding. No patient developed a pharyngocutaneous fistula. Three patients recovered their swallowing to their preoperative status and the remaining three experienced an improvement. All patients experienced complete recovery of their voice. RESA has the potential to provide a new organ preservation approach for head and neck cancer (HNC) not amenable to transoral exposure and thus warrants further prospective clinical studies.
我们报告了首例机器人辅助扩展“Sistrunk”入路(RESA)用于进入上呼吸道受限空间的临床经验。这项前瞻性病例队列研究纳入了 6 名如果无法经口暴露则行 RESA 的患者。其中 3 名患者曾接受过放疗。患者术后随访至第 16 周,以评估围手术期并发症、手术切缘和功能结局。所有患者的 RESA 均能提供充分的显露和阴性切缘的切除。3 名接受挽救性手术的患者发生轻微或中度术后出血。无患者发生咽皮瘘。3 名患者的吞咽功能恢复到术前状态,其余 3 名患者的吞咽功能得到改善。所有患者的声音均完全恢复。RESA 有可能为不能经口暴露的头颈部癌症(HNC)提供一种新的器官保留方法,因此值得进一步进行前瞻性临床研究。